SEC Form 4 · accession 0001179110-16-025315
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
May 20, 2016
Accepted (ET)
May 23, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2016 | S | 406 | $10.40 | D | 184,576 | D | |
| Common Stock | May 20, 2016 | S | 377 | $10.40 | D | 184,199 | D | |
| Common Stock | May 20, 2016 | S | 217 | $10.40 | D | 183,982 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.